在阿片类激动剂治疗中加入心理社会干预措施并不能进一步减少非法阿片类药物的使用：对杜戈什等人的评论
When Added to Opioid Agonist Treatment, Psychosocial Interventions do not Further Reduce the Use of Illicit Opioids: A Comment on Dugosh et al.
作者信息
Schwartz Robert P
机构信息
Friends Research Institute; and Department of Psychiatry, Division of Alcohol and Drug Abuse, University of Maryland School of Medicine, Baltimore, Maryland.
出版信息
J Addict Med. 2016 Jul-Aug;10(4):283-5. doi: 10.1097/ADM.0000000000000236.
Abstract
This commentary reviews the limitations of the recent literature review by that examined the role of psychosocial interventions with medication for opioid addiction treatment. The commonly held belief that opioid agonist treatment alone is inferior treatment to such treatment combined with 'psychosocial' treatment (which many will understand to mean counseling) is not supported by the research evidence and it results in limitations on the use of these effective medications.
摘要
本评论回顾了最近一篇文献综述的局限性，该综述探讨了心理社会干预与药物治疗相结合在阿片类药物成瘾治疗中的作用。认为仅使用阿片类激动剂治疗不如与“心理社会”治疗（许多人会理解为咨询）相结合的治疗效果好这一普遍观点，并未得到研究证据的支持，而且这导致了这些有效药物在使用上的限制。
相似文献
1
When Added to Opioid Agonist Treatment, Psychosocial Interventions do not Further Reduce the Use of Illicit Opioids: A Comment on Dugosh et al.在阿片类激动剂治疗中加入心理社会干预措施并不能进一步减少非法阿片类药物的使用：对杜戈什等人的评论
J Addict Med. 2016 Jul-Aug;10(4):283-5. doi: 10.1097/ADM.0000000000000236.
2
Pain volatility and prescription opioid addiction treatment outcomes in patients with chronic pain.慢性疼痛患者的疼痛波动性与处方阿片类药物成瘾治疗结果
Exp Clin Psychopharmacol. 2015 Dec;23(6):428-35. doi: 10.1037/pha0000039. Epub 2015 Aug 24.
3
American Society of Addiction Medicine (ASAM) National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use.美国成瘾医学协会（ASAM）关于使用药物治疗阿片类药物使用成瘾的国家实践指南。
J Addict Med. 2015 Sep-Oct;9(5):358-67. doi: 10.1097/ADM.0000000000000166.
4
Commentary on Bechara et al.'s "A Neurobehavioral Approach to Addiction: Implications for the Opioid Epidemic and the Psychology of Addiction".对贝查拉等人的《成瘾的神经行为方法：对阿片类药物流行及成瘾心理学的启示》的评论
Psychol Sci Public Interest. 2019 Oct;20(2):91-95. doi: 10.1177/1529100619862034.
5
The New Kid on the Block--Incorporating Buprenorphine into a Medical Toxicology Practice.新成员——将丁丙诺啡纳入医学毒理学实践
J Med Toxicol. 2016 Mar;12(1):64-70. doi: 10.1007/s13181-015-0518-4.
6
The intergenerational persistence of opioid dependence: Evidence from administrative data.代际间阿片类药物依赖的持续性：来自行政数据的证据。
Health Econ. 2022 Nov;31(11):2425-2444. doi: 10.1002/hec.4589. Epub 2022 Aug 15.
7
Opioids in the management of HIV-related pain.阿片类药物在管理 HIV 相关疼痛中的应用。
Pain Physician. 2012 Jul;15(3 Suppl):ES157-68.
8
The evolution of chronic opioid therapy and recognizing addiction.慢性阿片类药物治疗的演变与成瘾识别
JAAPA. 2015 May;28(5):23-7. doi: 10.1097/01.JAA.0000464268.60257.ad.
9
A typology of people who tamper with pharmaceutical opioids: responses to introduction of a tamper-resistant formulation of controlled-release oxycodone.滥用阿片类药物者的类型学：对引入控释羟考酮防篡改剂型的反应
Pharmacoepidemiol Drug Saf. 2015 Dec;24(12):1321-33. doi: 10.1002/pds.3883. Epub 2015 Sep 30.
10
Chronic Pain, Chronic Opioid Addiction: a Complex Nexus.慢性疼痛与慢性阿片类药物成瘾：一个复杂的关联
J Med Toxicol. 2016 Mar;12(1):54-7. doi: 10.1007/s13181-015-0521-9.
引用本文的文献
1
Immediate Effects of Mindful Awareness in Body-Oriented Therapy as an Adjunct to Medication for Opioid Use Disorder.正念觉察在以身体为导向的疗法中作为阿片类物质使用障碍药物治疗辅助手段的即时效果。
Mindfulness (N Y). 2024 Nov;15(11):2794-2811. doi: 10.1007/s12671-024-02463-x. Epub 2024 Nov 19.
2
Immediate Effects of Mindful Awareness in Body-oriented Therapy as an Adjunct to Medication for Opioid Use Disorder.正念觉知在以身体为导向的治疗中作为阿片类物质使用障碍药物治疗辅助手段的即时效果。
Res Sq. 2024 Jul 15:rs.3.rs-4727162. doi: 10.21203/rs.3.rs-4727162/v1.
3
Nonopioid Substance Use among Patients Who Recently Initiated Office-based Buprenorphine Treatment.近期接受门诊丁丙诺啡舌下片治疗的患者中的非阿片类物质使用情况。
J Addict Med. 2023;17(5):612-614. doi: 10.1097/ADM.0000000000001168. Epub 2023 Apr 18.
4
Opioid use disorder treatment and the role of New Jersey Medicaid policy changes: perspectives of office-based buprenorphine providers.阿片类药物使用障碍治疗与新泽西州医疗补助政策变化的作用：基层美沙酮维持治疗提供者的观点。
Am J Drug Alcohol Abuse. 2023 Sep 3;49(5):606-617. doi: 10.1080/00952990.2023.2234075. Epub 2023 Jul 28.
5
Shifting Medication Treatment Practices in the COVID-19 Pandemic: A Statewide Survey of Pennsylvania Opioid Treatment Programs.在 COVID-19 大流行期间改变药物治疗实践：宾夕法尼亚州阿片类药物治疗项目的全州调查。
J Addict Med. 2022;16(6):645-652. doi: 10.1097/ADM.0000000000000981.
6
Adjunct interventions to standard medical management of buprenorphine in outpatient settings: A systematic review of the evidence.门诊环境中辅助性干预措施联合丁丙诺啡标准药物管理：系统评价证据。
Drug Alcohol Depend. 2021 Nov 1;228:108923. doi: 10.1016/j.drugalcdep.2021.108923. Epub 2021 Jul 29.
7
Readiness to Provide Medications for Addiction Treatment in HIV Clinics: A Multisite Mixed-Methods Formative Evaluation.准备在 HIV 诊所提供成瘾治疗药物：一项多地点混合方法形成性评估。
J Acquir Immune Defic Syndr. 2021 Jul 1;87(3):959-970. doi: 10.1097/QAI.0000000000002666.
8
"It's way more than just writing a prescription": A qualitative study of preferences for integrated versus non-integrated treatment models among individuals with opioid use disorder.“这不仅仅是开个处方那么简单”：一项关于阿片类药物使用障碍患者对整合与非整合治疗模式偏好的定性研究。
Addict Sci Clin Pract. 2021 Jan 27;16(1):8. doi: 10.1186/s13722-021-00213-1.
本文引用的文献
1
A Systematic Review on the Use of Psychosocial Interventions in Conjunction With Medications for the Treatment of Opioid Addiction.关于心理社会干预联合药物治疗阿片类药物成瘾的系统评价
J Addict Med. 2016 Mar-Apr;10(2):93-103. doi: 10.1097/ADM.0000000000000193.
2
A randomized pilot clinical trial to evaluate the efficacy of Community Reinforcement and Family Training for Treatment Retention (CRAFT-T) for improving outcomes for patients completing opioid detoxification.一项随机试点临床试验，旨在评估社区强化与家庭训练促进治疗维持（CRAFT-T）对改善完成阿片类药物脱毒治疗患者结局的疗效。
Drug Alcohol Depend. 2014 May 1;138:240-3. doi: 10.1016/j.drugalcdep.2014.02.013. Epub 2014 Feb 23.
3
Web-based behavioral treatment for substance use disorders as a partial replacement of standard methadone maintenance treatment.基于网络的行为治疗用于物质使用障碍，作为标准美沙酮维持治疗的部分替代。
J Subst Abuse Treat. 2014 Jan;46(1):43-51. doi: 10.1016/j.jsat.2013.08.012. Epub 2013 Sep 21.
4
Effectiveness of prize-based contingency management in a methadone maintenance program in China.基于奖励的权变管理在我国美沙酮维持治疗项目中的效果。
Drug Alcohol Depend. 2013 Nov 1;133(1):270-4. doi: 10.1016/j.drugalcdep.2013.05.028. Epub 2013 Jul 4.
5
Comparison of behavioral treatment conditions in buprenorphine maintenance.比较丁丙诺啡维持治疗中的行为治疗条件。
Addiction. 2013 Oct;108(10):1788-98. doi: 10.1111/add.12266. Epub 2013 Jul 12.
6
A randomized trial of cognitive behavioral therapy in primary care-based buprenorphine.在基于初级保健的丁丙诺啡的认知行为疗法的随机试验中。
Am J Med. 2013 Jan;126(1):74.e11-7. doi: 10.1016/j.amjmed.2012.07.005.
7
Employment-based reinforcement of adherence to oral naltrexone treatment in unemployed injection drug users.以就业为基础加强对失业注射吸毒者口服美沙酮维持治疗的依从性。
Exp Clin Psychopharmacol. 2013 Feb;21(1):74-83. doi: 10.1037/a0030743. Epub 2012 Dec 3.
8
The effect of telephonic patient support on treatment for opioid dependence: outcomes at one year follow-up.电话患者支持对阿片类药物依赖治疗的效果：一年随访时的结果。
Addict Behav. 2012 May;37(5):686-9. doi: 10.1016/j.addbeh.2012.01.013. Epub 2012 Jan 25.
9
Impact of methadone with versus without drug abuse counseling on HIV risk: 4- and 12-month findings from a clinical trial.美沙酮联合与不联合药物滥用咨询对 HIV 风险的影响：一项临床试验的 4 个月和 12 个月结果。
J Addict Med. 2012 Jun;6(2):145-52. doi: 10.1097/ADM.0b013e31823ae556.
10
Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial.在短期和长期丁丙诺啡-纳洛酮治疗处方阿片类药物依赖期间的辅助咨询：一项两阶段随机对照试验。
Arch Gen Psychiatry. 2011 Dec;68(12):1238-46. doi: 10.1001/archgenpsychiatry.2011.121. Epub 2011 Nov 7.
Zotero 插件